Matthew Ross Boyd - 08 Jul 2025 Form 3 Insider Report for enGene Holdings Inc. (ENGN)

Reporting relationship: Chief Regulatory Officer
Issuer ticker: ENGN
Reported as of: 08 Jul 2025
Net transaction value: $0
SEC form: 3
Accepted by SEC: 14 Jul 2025, 16:09:12 UTC
Next SEC filing: 03 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Lee Giguere, as attorney-in-fact for the Reporting Person

Key filing fact

Matthew Ross Boyd filed Form 3 for enGene Holdings Inc. (ENGN) on 14 Jul 2025.

Key facts

This page summarizes Matthew Ross Boyd's Form 3 filing for enGene Holdings Inc. (ENGN).
0 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 14 Jul 2025, 16:09.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002077001 Primary reporting owner

Boyd Matthew Ross

Relationship: Chief Regulatory Officer
Address: C/O 4868 RUE LEVY, SUITE 220, SAINT-LAURENT, QUEBEC, CANADA
Signature: /s/ Lee Giguere, as attorney-in-fact for the Reporting Person
Signature date: 14 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENGN holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 08 Jul 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ENGN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 08 Jul 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 68,000
Exercise price: $6.60
Footnotes: F1

ENGN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 08 Jul 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 51,000
Exercise price: $7.39
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Non-qualified stock option grant awarded as an inducement award outside of the Amended and Restated enGene Holdings Inc. 2023 Incentive Equity Plan in accordance with NASDAQ Listing Rule 5635(c)(4). This option vests at 25% on September 16, 2025, which is the first anniversary of the employment commencement date, with the remaining portion to vest monthly over the next three years, subject to the reporting person's continued service.

Footnote F2

This option vests in equal monthly installments over forty-eight (48) months on the last day of each month commencing January 29, 2025, subject to the reporting person's continued service.

SEC remarks

Exhibit 24 - Power of Attorney